| Multicenter analytical evaluation of a high-sensitivity troponin T assay AK Saenger, R Beyrau, S Braun, R Cooray, A Dolci, H Freidank, ... Clinica chimica acta 412 (9-10), 748-754, 2011 | 414 | 2011 |
| Earlier detection of myocardial injury in a preliminary evaluation using a new troponin I assay with improved sensitivity SEF Melanson, DA Morrow, P Jarolim American journal of clinical pathology 128 (2), 282-286, 2007 | 296 | 2007 |
| Cardiac troponin assays: a view from the clinical chemistry laboratory SEF Melanson, MJ Tanasijevic, P Jarolim Circulation 116 (18), e501-e504, 2007 | 109 | 2007 |
| Applying Lean/Toyota production system principles to improve phlebotomy patient satisfaction and workflow SEF Melanson, EM Goonan, MM Lobo, JM Baum, JD Paredes, KS Santos, ... American journal of clinical pathology 132 (6), 914-919, 2009 | 99 | 2009 |
| Reduction in specimen labeling errors after implementation of a positive patient identification system in phlebotomy AP Morrison, MJ Tanasijevic, EM Goonan, MM Lobo, MM Bates, ... American journal of clinical pathology 133 (6), 870-877, 2010 | 90 | 2010 |
| What proportion of vancomycin trough levels are drawn too early? Frequency and impact on clinical actions AP Morrison, SEF Melanson, MG Carty, DW Bates, PM Szumita, ... American journal of clinical pathology 137 (3), 472-478, 2012 | 78 | 2012 |
| The utility of immunoassays for urine drug testing SEF Melanson Clinics in laboratory medicine 32 (3), 429-447, 2012 | 76 | 2012 |
| Selecting automation for the clinical chemistry laboratory SEF Melanson, NI Lindeman, P Jarolim Archives of pathology & laboratory medicine 131 (7), 1063-1069, 2007 | 62 | 2007 |
| High-dose biotin treatment for secondary progressive multiple sclerosis may interfere with thyroid assays A Minkovsky, MN Lee, M Dowlatshahi, TE Angell, LS Mahrokhian, ... AACE clinical case reports 2 (4), e370-e373, 2016 | 59 | 2016 |
| Quality control practices for chemistry and immunochemistry in a cohort of 21 large academic medical centers MW Rosenbaum, JG Flood, SEF Melanson, NA Baumann, MA Marzinke, ... American journal of clinical pathology 150 (2), 96-104, 2018 | 57 | 2018 |
| Implementation of a highly sensitive cardiac troponin I assay: test volumes, positivity rates and interpretation of results SEF Melanson, MJ Conrad, N Mosammaparast, P Jarolim Clinica Chimica Acta 395 (1-2), 57-61, 2008 | 56 | 2008 |
| Elevation of myeloperoxidase in conjunction with cardiac-specific markers after marathon running SEF Melanson, SM Green, MJ Wood, TG Neilan, EL Lewandrowski American journal of clinical pathology 126 (6), 888-893, 2006 | 54 | 2006 |
| Utilization of arterial blood gas measurements in a large tertiary care hospital SEF Melanson, T Szymanski, SO Rogers Jr, P Jarolim, G Frendl, JD Rawn, ... American journal of clinical pathology 127 (4), 604-609, 2007 | 53 | 2007 |
| Electronic patient identification for sample labeling reduces wrong blood in tube errors RM Kaufman, A Dinh, CS Cohn, MK Fung, J Gorlin, S Melanson, ... Transfusion 59 (3), 972-980, 2019 | 50 | 2019 |
| KIMS, CEDIA, and HS-CEDIA immunoassays are inadequately sensitive for detection of benzodiazepines in urine from patients treated for chronic pain A Darragh, ML Snyder, AS Ptolemy, S Melanson Pain Physician 17 (4), 359, 2014 | 49 | 2014 |
| Interpretation and utility of drug of abuse immunoassays: lessons from laboratory drug testing surveys SEF Melanson, L Baskin, B Magnani, TC Kwong, A Dizon, AHB Wu Archives of pathology & laboratory medicine 134 (5), 735-739, 2010 | 42 | 2010 |
| A new highly specific buprenorphine immunoassay for monitoring buprenorphine compliance and abuse SEF Melanson, ML Snyder, P Jarolim, JG Flood Journal of analytical toxicology 36 (3), 201-206, 2012 | 41 | 2012 |
| Reduced interference by phenothiazines in amphetamine drug of abuse immunoassays SEF Melanson, E Lee-Lewandrowski, DA Griggs, WH Long, JG Flood Archives of Pathology & Laboratory Medicine 130 (12), 1834-1838, 2006 | 38 | 2006 |
| Laboratory Testing for B-Type Natriuretic Peptides (BNP and NT-proBNP) Clinical Usefulness, Utilization, and Impact on Hospital Operations SEF Melanson, EL Lewandrowski Pathology Patterns Reviews 124 (suppl_1), S122-S128, 2005 | 38 | 2005 |
| Optimizing urine drug testing for monitoring medication compliance in pain management SEF Melanson, AS Ptolemy, AD Wasan Pain Medicine 14 (12), 1813-1820, 2013 | 36 | 2013 |
